Search research articles
Contact Us
Filters
Showing results (341-350 of 484) with videos related to
Page
of 49
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1995
Ig gamma 2b transgenes promote B cell development but alternate developmental pathways appear to function in different transgenic lines
J J Kenny, A M Stall, R T Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1989
Hypothyroidism after interleukin-2 therapy
L C Hartmann, W J Urba, R G Steis, et al.
Seminars in Oncology
|
February 1, 1995
Cellular and molecular studies in the treatment of murine renal cancer
R H Wiltrout, T A Gregorio, R G Fenton, et al.
Cancer Research
|
May 15, 1993
Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment
B D Curti, W J Urba, W G Alvord, et al.
Blood
|
April 1, 1996
Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection
P Schwarzenberger, S Spence, N Lohrey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1991
Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits
R L Geller, M J Smyth, S L Strobl, et al.
The Journal of Experimental Medicine
|
September 1, 1994
Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin
K Grzegorzewski, F W Ruscetti, N Usui, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1995
IL-4 inhibits IL-2-induced tumoricidal activity and secretory functions of human monocytes. Modulation of IL-2 binding and IL-2 receptor beta gamma chain expression
M C Bosco, K Pulkki, T K Rowe, et al.
Annals of Internal Medicine
|
May 1, 1984
Prolonged initial remission in patients with nodular mixed lymphoma
D L Longo, R C Young, S M Hubbard, et al.
Neuroimmunomodulation
|
January 7, 1999
Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation
M A Woody, L A Welniak, S Richards, et al.
Page
of 49
Search research articles
Search
Showing results (341-350 of 484) with videos related to
Sort By:
Page
of 49
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1995
Ig gamma 2b transgenes promote B cell development but alternate developmental pathways appear to function in different transgenic lines
J J Kenny, A M Stall, R T Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1989
Hypothyroidism after interleukin-2 therapy
L C Hartmann, W J Urba, R G Steis, et al.
Seminars in Oncology
|
February 1, 1995
Cellular and molecular studies in the treatment of murine renal cancer
R H Wiltrout, T A Gregorio, R G Fenton, et al.
Cancer Research
|
May 15, 1993
Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment
B D Curti, W J Urba, W G Alvord, et al.
Blood
|
April 1, 1996
Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection
P Schwarzenberger, S Spence, N Lohrey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1991
Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits
R L Geller, M J Smyth, S L Strobl, et al.
The Journal of Experimental Medicine
|
September 1, 1994
Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin
K Grzegorzewski, F W Ruscetti, N Usui, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1995
IL-4 inhibits IL-2-induced tumoricidal activity and secretory functions of human monocytes. Modulation of IL-2 binding and IL-2 receptor beta gamma chain expression
M C Bosco, K Pulkki, T K Rowe, et al.
Annals of Internal Medicine
|
May 1, 1984
Prolonged initial remission in patients with nodular mixed lymphoma
D L Longo, R C Young, S M Hubbard, et al.
Neuroimmunomodulation
|
January 7, 1999
Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation
M A Woody, L A Welniak, S Richards, et al.
Page
of 49